Pacific Edge in trading halt as Jarden ponders Novitas notice

Pacific Edge in trading halt as Jarden ponders Novitas notice
The future has just got murky. (Image: Pacific Edge)
Staff reporters
Jarden analysts are pondering the impact of Medicare contractor Novitas not covering Pacific Edge’s Cxbladder in its local cover determination, while the healthcare company’s shares are in a trading halt pending a material announcement Analyst Christian Bell said in a note that the decision is a “demonstrable change in circumstances” removing Medicare coverage in the US and calling into question “the foundational evidence that supports the clinical validity of all Cxbladder tests”. “The decisi...